Skip to content

To study the effect of Vanadium Metallicum in 12 homoeopathic centesimal potency in cases of type 2 diabetes mellitus

In-vitro analysis of anti-oxidant potential of vanadium metallicum 12c and validating through open label randomized control trial in Type ii Diabetes Mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067519
Enrollment
80
Registered
2024-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: vanadium 12c: Antioxidants are well recognized for lowering radioactive oxygen species (ROS) induced oxidative stress, which contributes to the onset of diabetes and its associated comp

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age groups 30-70 of both sex and of all Religion. FBS 125- 150 mg/dl. PPBS 200- 300 mg/dl. HbA1C 6.5- 8 % Out of above 3 any two. Patient willing to give written consent for participating in the study and complete follow-up during study. Patients who are able to read Bengali/English/Hindi

Exclusion criteria

Exclusion criteria: Patients age below 30 and above 70. Patients having severe complications like hypoglycaemia, retinopathy, neuropathy, diabetic foot, malignancy, severe cardiac disorders, HbA1C above 8, FBS above 150 mg/dl, PPBS above 300mg/dl or any other comorbidities. Immunocompromised patient. Patient suffering from any severe psychiatric illness. Patients not willing to give written consent. Patients not willing to undergo any investigation, if needed. Pregnant and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Changes in the Fasting Blood Sugar before and after treatmentTimepoint: 6 months

Secondary

MeasureTime frame
antioxidant values of vanadium met 12 CTimepoint: within study period 6 months

Countries

India

Contacts

Public ContactNational Institute of Homoeopathy

National Institute of Homoeopathy

drkumaravelnih@gmail.com6265655857

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026